Safety of Arthritis Drugs, Day 2, Part 4
The Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2” inhib…
496 viewsThe Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees continued discussions in their joint meeting on possible safety of risks of “COX-2” inhib…
496 viewsSenate Finance Committee members met with witnesses who testified about the approval process for new drugs at the Food and Drug Administration, the recent recall of the medication Vioxx, the…
1,177 views